The Role of PTX3 in Mineralization Processes and Aging-Related Bone Diseases.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2020
Historique:
received: 29 10 2020
accepted: 16 12 2020
entrez: 15 2 2021
pubmed: 16 2 2021
medline: 24 6 2021
Statut: epublish

Résumé

The Long Pentraxin 3 (PTX3) is a multifunctional glycoprotein released by peripheral blood leukocytes and myeloid dendritic cells in response to primary pro-inflammatory stimuli, that acts as a non-redundant component of the humoral arm of innate immunity. In addition to the primary role in the acute inflammatory response, PTX3 seems to be involved in other physiological and pathological processes. Indeed, PTX3 seems to play a pivotal role in the deposition and remodeling of bone matrix during the mineralization process, promoting osteoblasts differentiation and activity. Recently, PTX3 was seen to be involved in the ectopic calcifications' formation in breast cancer disease. In this regard, it has been observed that breast cancer tumors characterized by high expression of PTX3 and high amount of Breast Osteoblast Like Cells (BOLCs) showed several Hydroxyapatite (HA) microcalcifications, suggesting a likely role for PTX3 in differentiation and osteoblastic activity in both bone and extra-bone sites. Furthermore, given its involvement in bone metabolism, several studies agree with the definition of PTX3 as a molecule significantly involved in the pathogenesis of age-related bone diseases, such as osteoporosis, both in mice and humans. Recent results suggest that genetic and epigenetic mechanisms acting on

Identifiants

pubmed: 33584725
doi: 10.3389/fimmu.2020.622772
pmc: PMC7878364
doi:

Substances chimiques

Nerve Tissue Proteins 0
Serum Amyloid P-Component 0
neuronal pentraxin 0
PTX3 protein 148591-49-5
C-Reactive Protein 9007-41-4

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

622772

Informations de copyright

Copyright © 2021 Tarantino, Greggi, Cariati, Visconti, Gasparini, Cateni, Gasbarra, Botta, Salustri and Scimeca.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Clin Breast Cancer. 2018 Aug;18(4):e659-e669
pubmed: 29306659
J Cell Physiol. 2014 Nov;229(11):1744-52
pubmed: 24664887
Physiol Int. 2019 Sep 1;106(3):283-293
pubmed: 31560233
Cancer Res. 2015 May 15;75(10):2120-30
pubmed: 25808873
Front Immunol. 2017 May 09;8:516
pubmed: 28536575
Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1419-23
pubmed: 19696407
Biochem Biophys Rep. 2016 Jan 14;5:290-295
pubmed: 28955836
Eat Weight Disord. 2018 Jun;23(3):375-381
pubmed: 28271457
Biosci Rep. 2020 Jun 26;40(6):
pubmed: 32436939
Med Sci Monit. 2016 Aug 18;22:2911-6
pubmed: 27538101
Muscles Ligaments Tendons J. 2017 May 10;7(1):200-201
pubmed: 28717630
Am J Respir Crit Care Med. 2012 Sep 15;186(6):546-52
pubmed: 22822025
Eur J Neurol. 2020 Jul;27(7):1279-1284
pubmed: 32250504
J Hepatol. 2016 Jun;64(6):1416-27
pubmed: 26921689
Biochim Biophys Acta. 2016 Jun;1862(6):1182-90
pubmed: 26976330
Contrast Media Mol Imaging. 2018 Dec 9;2018:9840962
pubmed: 30627063
J Invest Dermatol. 2016 Jan;136(1):293-300
pubmed: 26763449
Front Immunol. 2018 Mar 05;9:417
pubmed: 29556234
Future Oncol. 2018 Jan;14(1):9-11
pubmed: 29219614
J Mammary Gland Biol Neoplasia. 2018 Jun;23(1-2):89-99
pubmed: 29744755
Annu Rev Immunol. 2005;23:337-66
pubmed: 15771574
J Korean Med Sci. 2018 May 09;33(23):e165
pubmed: 29853820
Annu Rev Immunol. 2010;28:157-83
pubmed: 19968561
Curr Pharm Des. 2011;17(1):38-46
pubmed: 21226667
J Mammary Gland Biol Neoplasia. 2005 Apr;10(2):181-7
pubmed: 16025224
Br J Cancer. 2012 Jan 31;106(3):525-37
pubmed: 22233923
Cell Death Dis. 2017 Oct 12;8(10):e3125
pubmed: 29022895
Bone Res. 2019 Aug 5;7:22
pubmed: 31666997
J Biol Chem. 2008 Apr 11;283(15):10147-61
pubmed: 18223257
Future Oncol. 2018 Dec;14(30):3097-3099
pubmed: 30411977
Int J Cancer. 2021 Mar 15;148(6):1351-1359
pubmed: 32976625
J Biol Chem. 1992 Nov 5;267(31):22190-7
pubmed: 1429570
Int J Mol Sci. 2019 Nov 11;20(22):
pubmed: 31718020
Clin Chem Lab Med. 2009;47(4):471-7
pubmed: 19327124
PLoS One. 2012;7(12):e53030
pubmed: 23285251
Front Immunol. 2019 Nov 08;10:2628
pubmed: 31787987
J Exp Med. 2015 Jun 1;212(6):905-25
pubmed: 25964372
J Geriatr Cardiol. 2016 Aug;13(8):712-717
pubmed: 27781062
Crit Rev Clin Lab Sci. 2018 Nov;55(7):443-465
pubmed: 30265166
Bone. 2013 Apr;53(2):437-50
pubmed: 23334083
Tumour Biol. 2016 Apr;37(4):5427-35
pubmed: 26563370
Mol Biol Cell. 2004 Aug;15(8):3709-18
pubmed: 15181152
Nat Commun. 2014 Jun 24;2:4172
pubmed: 24960204
Front Immunol. 2019 Apr 04;10:712
pubmed: 31019517
J Biol Chem. 2010 Jun 4;285(23):17681-92
pubmed: 20363749

Auteurs

Umberto Tarantino (U)

Department of Clinical Science and Translational Medicine, University of Rome "Tor Vergata", Rome, Italy.
Department of Orthopedics and Traumatology, Policlinico Tor Vergata (PTV) Foundation, Rome, Italy.

Chiara Greggi (C)

Department of Orthopedics and Traumatology, Policlinico Tor Vergata (PTV) Foundation, Rome, Italy.
Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy.
PhD students' Program in Medical-Surgical and Biotechnologies and Translational Medicine, Faculty of Medicine and Surgery, University of Rome "Tor Vergata", Rome, Italy.

Ida Cariati (I)

Department of Orthopedics and Traumatology, Policlinico Tor Vergata (PTV) Foundation, Rome, Italy.
Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy.
PhD students' Program in Medical-Surgical and Biotechnologies and Translational Medicine, Faculty of Medicine and Surgery, University of Rome "Tor Vergata", Rome, Italy.

Virginia Veronica Visconti (VV)

Department of Orthopedics and Traumatology, Policlinico Tor Vergata (PTV) Foundation, Rome, Italy.
Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy.
PhD students' Program in Medical-Surgical and Biotechnologies and Translational Medicine, Faculty of Medicine and Surgery, University of Rome "Tor Vergata", Rome, Italy.

Monica Gasparini (M)

Department of Clinical Science and Translational Medicine, University of Rome "Tor Vergata", Rome, Italy.
Department of Orthopedics and Traumatology, Policlinico Tor Vergata (PTV) Foundation, Rome, Italy.

Marco Cateni (M)

Department of Clinical Science and Translational Medicine, University of Rome "Tor Vergata", Rome, Italy.
Department of Orthopedics and Traumatology, Policlinico Tor Vergata (PTV) Foundation, Rome, Italy.

Elena Gasbarra (E)

Department of Clinical Science and Translational Medicine, University of Rome "Tor Vergata", Rome, Italy.
Department of Orthopedics and Traumatology, Policlinico Tor Vergata (PTV) Foundation, Rome, Italy.

Annalisa Botta (A)

Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy.

Antonietta Salustri (A)

Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy.

Manuel Scimeca (M)

Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH